HEADER HYDROLASE/HYDROLASE INHIBITOR 22-OCT-91 1PSA TITLE STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL TITLE 2 CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE TITLE 3 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPSIN A; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.23.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823 KEYWDS ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.CHEN,C.ABAD-ZAPATERO REVDAT 6 29-NOV-17 1PSA 1 REMARK HELIX REVDAT 5 13-JUL-11 1PSA 1 VERSN REVDAT 4 25-AUG-09 1PSA 1 SOURCE REVDAT 3 24-FEB-09 1PSA 1 VERSN REVDAT 2 01-APR-03 1PSA 1 JRNL REVDAT 1 31-JAN-94 1PSA 0 JRNL AUTH L.CHEN,J.W.ERICKSON,T.J.RYDEL,C.H.PARK,D.NEIDHART,J.LULY, JRNL AUTH 2 C.ABAD-ZAPATERO JRNL TITL STRUCTURE OF A PEPSIN/RENIN INHIBITOR COMPLEX REVEALS A JRNL TITL 2 NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS JRNL TITL 3 IN THE INHIBITOR. JRNL REF ACTA CRYSTALLOGR.,SECT.B V. 48 476 1992 JRNL REFN ISSN 0108-7681 JRNL PMID 1418819 JRNL DOI 10.1107/S0108768192001939 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.ABAD-ZAPATERO,T.J.RYDEL,D.J.NEIDHART,J.LULY,J.W.ERICKSON REMARK 1 TITL INHIBITOR BINDING INDUCES STRUCTURAL CHANGES IN PORCINE REMARK 1 TITL 2 PEPSIN REMARK 1 REF ADV.EXP.MED.BIOL. V. 306 9 1991 REMARK 1 REFN ISSN 0065-2598 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.ABAD-ZAPATERO,T.J.RYDEL,J.ERICKSON REMARK 1 TITL REVISED 2.3 ANGSTROMS STRUCTURE OF PORCINE PEPSIN: EVIDENCE REMARK 1 TITL 2 FOR A FLEXIBLE SUBDOMAIN REMARK 1 REF PROTEINS V. 8 62 1990 REMARK 1 REFN ISSN 0887-3585 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4858 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 3.170 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE SPACE GROUP OF THIS STRUCTURE IS MONOCLINIC P21, WITH REMARK 3 C AXIS UNIQUE. THE ASYMMETRIC UNIT CONTAINS TWO PEPSIN/ REMARK 3 INHIBITOR COMPLEXES. REMARK 3 REMARK 3 RESIDUES 239 - 242 AND 278 - 281 OF CHAINS *A* AND *B* HAD REMARK 3 THE WEAKEST ELECTRON DENSITY. REMARK 4 REMARK 4 1PSA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 1 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.25000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE TRANSFORMATION PRESENTED ON *MTRIX* RECORDS BELOW WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR CHAIN *B* WHEN APPLIED TO REMARK 300 CHAIN *A*. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU A 166 CG CD2 REMARK 480 ASN A 263 ND2 REMARK 480 LEU B 166 CG CD2 REMARK 480 ASN B 263 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 53 NE2 HIS A 53 CD2 -0.074 REMARK 500 HIS B 53 NE2 HIS B 53 CD2 -0.071 REMARK 500 LEU B 166 CB LEU B 166 CG -0.183 REMARK 500 LEU B 166 CG LEU B 166 CD1 0.285 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 26 CB - CA - C ANGL. DEV. = -17.9 DEGREES REMARK 500 ASP A 26 N - CA - CB ANGL. DEV. = 12.2 DEGREES REMARK 500 TRP A 39 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP A 39 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP A 141 CD1 - CG - CD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 TRP A 141 CE2 - CD2 - CG ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP A 160 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 160 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 TRP A 181 CD1 - CG - CD2 ANGL. DEV. = 7.6 DEGREES REMARK 500 TRP A 181 CG - CD1 - NE1 ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP A 181 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP A 190 CD1 - CG - CD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 TRP A 190 CE2 - CD2 - CG ANGL. DEV. = -5.4 DEGREES REMARK 500 CYS A 206 CB - CA - C ANGL. DEV. = 7.3 DEGREES REMARK 500 CYS A 206 CA - CB - SG ANGL. DEV. = 7.4 DEGREES REMARK 500 TRP A 299 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP A 299 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TYR B 9 CB - CG - CD2 ANGL. DEV. = -5.0 DEGREES REMARK 500 TRP B 39 CD1 - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP B 39 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TYR B 44 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 TRP B 141 CD1 - CG - CD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 TRP B 141 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 LEU B 166 CA - CB - CG ANGL. DEV. = 15.6 DEGREES REMARK 500 LEU B 166 CB - CG - CD1 ANGL. DEV. = -15.4 DEGREES REMARK 500 TRP B 181 CD1 - CG - CD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 TRP B 181 CB - CG - CD1 ANGL. DEV. = -9.1 DEGREES REMARK 500 TRP B 181 CG - CD1 - NE1 ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP B 181 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP B 181 CG - CD2 - CE3 ANGL. DEV. = 6.6 DEGREES REMARK 500 TRP B 190 CD1 - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TRP B 190 CE2 - CD2 - CG ANGL. DEV. = -5.6 DEGREES REMARK 500 TYR B 267 CB - CG - CD1 ANGL. DEV. = -3.7 DEGREES REMARK 500 ASP B 279 CA - CB - CG ANGL. DEV. = 13.2 DEGREES REMARK 500 TRP B 299 CD1 - CG - CD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 TRP B 299 CG - CD1 - NE1 ANGL. DEV. = -6.2 DEGREES REMARK 500 TRP B 299 CE2 - CD2 - CG ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP B 299 CG - CD2 - CE3 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 11 13.13 54.49 REMARK 500 PRO A 116 23.98 -68.97 REMARK 500 ALA A 124 -158.66 -99.89 REMARK 500 ASP A 149 47.58 -83.75 REMARK 500 MET A 199 112.14 -161.06 REMARK 500 CYS A 206 72.06 53.10 REMARK 500 ASN A 240 -87.50 -115.53 REMARK 500 ASP A 279 -111.54 63.13 REMARK 500 VAL A 291 75.59 -119.93 REMARK 500 ASP B 52 31.49 -86.70 REMARK 500 PHE B 111 -71.89 -29.15 REMARK 500 SER B 131 16.88 59.53 REMARK 500 ASP B 149 53.53 -92.75 REMARK 500 THR B 225 -64.65 -20.61 REMARK 500 ASN B 240 -123.11 -104.55 REMARK 500 ASP B 242 96.19 74.82 REMARK 500 ASP B 279 -85.30 54.45 REMARK 500 MET B 289 108.65 -165.66 REMARK 500 SER B 295 32.37 -95.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR A-62095 IS A TETRAPEPTIDE ANALOGUE WITH A REMARK 600 T-BOC BLOCKING GROUP AND CONTAINING CYCLOHEXYL REMARK 600 ALANINE AT THE P1 POSITION (XAO). REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(ETHOXYCARBONYL)-L-LEUCYL-N-[(1R,2S,3S)-1- REMARK 630 (CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L-LEUCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0ZL A 327 REMARK 630 0ZL B 327 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 0AG LEU XAO REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZL A 327 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZL B 327 DBREF 1PSA A 1 326 UNP P00791 PEPA_PIG 60 386 DBREF 1PSA B 1 326 UNP P00791 PEPA_PIG 60 386 SEQADV 1PSA A UNP P00791 ILE 289 DELETION SEQADV 1PSA B UNP P00791 ILE 289 DELETION SEQRES 1 A 326 ILE GLY ASP GLU PRO LEU GLU ASN TYR LEU ASP THR GLU SEQRES 2 A 326 TYR PHE GLY THR ILE GLY ILE GLY THR PRO ALA GLN ASP SEQRES 3 A 326 PHE THR VAL ILE PHE ASP THR GLY SER SER ASN LEU TRP SEQRES 4 A 326 VAL PRO SER VAL TYR CYS SER SER LEU ALA CYS SER ASP SEQRES 5 A 326 HIS ASN GLN PHE ASN PRO ASP ASP SER SER THR PHE GLU SEQRES 6 A 326 ALA THR SER GLN GLU LEU SER ILE THR TYR GLY THR GLY SEQRES 7 A 326 SER MET THR GLY ILE LEU GLY TYR ASP THR VAL GLN VAL SEQRES 8 A 326 GLY GLY ILE SER ASP THR ASN GLN ILE PHE GLY LEU SER SEQRES 9 A 326 GLU THR GLU PRO GLY SER PHE LEU TYR TYR ALA PRO PHE SEQRES 10 A 326 ASP GLY ILE LEU GLY LEU ALA TYR PRO SER ILE SER ALA SEQRES 11 A 326 SER GLY ALA THR PRO VAL PHE ASP ASN LEU TRP ASP GLN SEQRES 12 A 326 GLY LEU VAL SER GLN ASP LEU PHE SER VAL TYR LEU SER SEQRES 13 A 326 SER ASN ASP ASP SER GLY SER VAL VAL LEU LEU GLY GLY SEQRES 14 A 326 ILE ASP SER SER TYR TYR THR GLY SER LEU ASN TRP VAL SEQRES 15 A 326 PRO VAL SER VAL GLU GLY TYR TRP GLN ILE THR LEU ASP SEQRES 16 A 326 SER ILE THR MET ASP GLY GLU THR ILE ALA CYS SER GLY SEQRES 17 A 326 GLY CYS GLN ALA ILE VAL ASP THR GLY THR SER LEU LEU SEQRES 18 A 326 THR GLY PRO THR SER ALA ILE ALA ASN ILE GLN SER ASP SEQRES 19 A 326 ILE GLY ALA SER GLU ASN SER ASP GLY GLU MET VAL ILE SEQRES 20 A 326 SER CYS SER SER ILE ASP SER LEU PRO ASP ILE VAL PHE SEQRES 21 A 326 THR ILE ASN GLY VAL GLN TYR PRO LEU SER PRO SER ALA SEQRES 22 A 326 TYR ILE LEU GLN ASP ASP ASP SER CYS THR SER GLY PHE SEQRES 23 A 326 GLU GLY MET ASP VAL PRO THR SER SER GLY GLU LEU TRP SEQRES 24 A 326 ILE LEU GLY ASP VAL PHE ILE ARG GLN TYR TYR THR VAL SEQRES 25 A 326 PHE ASP ARG ALA ASN ASN LYS VAL GLY LEU ALA PRO VAL SEQRES 26 A 326 ALA SEQRES 1 B 326 ILE GLY ASP GLU PRO LEU GLU ASN TYR LEU ASP THR GLU SEQRES 2 B 326 TYR PHE GLY THR ILE GLY ILE GLY THR PRO ALA GLN ASP SEQRES 3 B 326 PHE THR VAL ILE PHE ASP THR GLY SER SER ASN LEU TRP SEQRES 4 B 326 VAL PRO SER VAL TYR CYS SER SER LEU ALA CYS SER ASP SEQRES 5 B 326 HIS ASN GLN PHE ASN PRO ASP ASP SER SER THR PHE GLU SEQRES 6 B 326 ALA THR SER GLN GLU LEU SER ILE THR TYR GLY THR GLY SEQRES 7 B 326 SER MET THR GLY ILE LEU GLY TYR ASP THR VAL GLN VAL SEQRES 8 B 326 GLY GLY ILE SER ASP THR ASN GLN ILE PHE GLY LEU SER SEQRES 9 B 326 GLU THR GLU PRO GLY SER PHE LEU TYR TYR ALA PRO PHE SEQRES 10 B 326 ASP GLY ILE LEU GLY LEU ALA TYR PRO SER ILE SER ALA SEQRES 11 B 326 SER GLY ALA THR PRO VAL PHE ASP ASN LEU TRP ASP GLN SEQRES 12 B 326 GLY LEU VAL SER GLN ASP LEU PHE SER VAL TYR LEU SER SEQRES 13 B 326 SER ASN ASP ASP SER GLY SER VAL VAL LEU LEU GLY GLY SEQRES 14 B 326 ILE ASP SER SER TYR TYR THR GLY SER LEU ASN TRP VAL SEQRES 15 B 326 PRO VAL SER VAL GLU GLY TYR TRP GLN ILE THR LEU ASP SEQRES 16 B 326 SER ILE THR MET ASP GLY GLU THR ILE ALA CYS SER GLY SEQRES 17 B 326 GLY CYS GLN ALA ILE VAL ASP THR GLY THR SER LEU LEU SEQRES 18 B 326 THR GLY PRO THR SER ALA ILE ALA ASN ILE GLN SER ASP SEQRES 19 B 326 ILE GLY ALA SER GLU ASN SER ASP GLY GLU MET VAL ILE SEQRES 20 B 326 SER CYS SER SER ILE ASP SER LEU PRO ASP ILE VAL PHE SEQRES 21 B 326 THR ILE ASN GLY VAL GLN TYR PRO LEU SER PRO SER ALA SEQRES 22 B 326 TYR ILE LEU GLN ASP ASP ASP SER CYS THR SER GLY PHE SEQRES 23 B 326 GLU GLY MET ASP VAL PRO THR SER SER GLY GLU LEU TRP SEQRES 24 B 326 ILE LEU GLY ASP VAL PHE ILE ARG GLN TYR TYR THR VAL SEQRES 25 B 326 PHE ASP ARG ALA ASN ASN LYS VAL GLY LEU ALA PRO VAL SEQRES 26 B 326 ALA HET 0ZL A 327 38 HET 0ZL B 327 38 HETNAM 0ZL N-(ETHOXYCARBONYL)-L-LEUCYL-N-[(1R,2S,3S)-1- HETNAM 2 0ZL (CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L- HETNAM 3 0ZL LEUCINAMIDE FORMUL 3 0ZL 2(C29 H55 N3 O6) FORMUL 5 HOH *110(H2 O) HELIX 1 H1A LEU A 48 SER A 51 5 4 HELIX 2 H2A SER A 110 TYR A 114 1 5 HELIX 3 H3A VAL A 136 ASP A 142 1 7 HELIX 4 H4A THR A 225 ILE A 235 1 11 HELIX 5 H5A CYS A 249 SER A 254 1ALSO TYPE 5 6 HELIX 6 H6A PRO A 271 TYR A 274 1ALSO TYPE 5 4 HELIX 7 H7A ASP A 303 GLN A 308 1ALSO TYPE 5 6 HELIX 8 H1B LEU B 48 SER B 51 5 4 HELIX 9 H2B SER B 110 TYR B 114 1 5 HELIX 10 H3B VAL B 136 ASP B 142 1 7 HELIX 11 H4B THR B 225 ILE B 235 1 11 HELIX 12 H5B CYS B 249 SER B 254 1ALSO TYPE 5 6 HELIX 13 H6B PRO B 271 TYR B 274 1ALSO TYPE 5 4 HELIX 14 H7B ASP B 303 GLN B 308 1ALSO TYPE 5 6 SHEET 1 1AA 6 GLY A 2 LEU A 6 0 SHEET 2 1AA 6 SER A 163 GLY A 168 -1 N VAL A 165 O GLU A 4 SHEET 3 1AA 6 ASP A 149 TYR A 154 -1 N SER A 152 O LEU A 166 SHEET 4 1AA 6 GLN A 308 ALA A 316 -1 N THR A 311 O VAL A 153 SHEET 5 1AA 6 ASN A 318 VAL A 325 -1 N ALA A 323 O TYR A 310 SHEET 6 1AA 6 THR A 176 THR A 176 -1 N THR A 176 O PRO A 324 SHEET 1 1BA 6 GLY A 2 LEU A 6 0 SHEET 2 1BA 6 SER A 163 GLY A 168 -1 N VAL A 165 O GLU A 4 SHEET 3 1BA 6 ASP A 149 TYR A 154 -1 N SER A 152 O LEU A 166 SHEET 4 1BA 6 GLN A 308 ALA A 316 -1 N THR A 311 O VAL A 153 SHEET 5 1BA 6 ASN A 318 VAL A 325 -1 N ALA A 323 O TYR A 310 SHEET 6 1BA 6 LEU A 179 VAL A 184 -1 N VAL A 184 O ASN A 318 SHEET 1 2A 4 PRO A 23 PHE A 27 0 SHEET 2 2A 4 ILE A 18 GLY A 21 -1 N ILE A 20 O GLN A 25 SHEET 3 2A 4 THR A 88 VAL A 91 -1 N GLN A 90 O GLY A 19 SHEET 4 2A 4 ILE A 94 ASP A 96 -1 N ILE A 94 O VAL A 91 SHEET 1 3A 4 GLU A 202 ALA A 205 0 SHEET 2 3A 4 SER A 196 MET A 199 -1 N ILE A 197 O ALA A 205 SHEET 3 3A 4 ILE A 258 ILE A 262 -1 N VAL A 259 O THR A 198 SHEET 4 3A 4 VAL A 265 LEU A 269 -1 N TYR A 267 O PHE A 260 SHEET 1 4A 3 LEU A 71 TYR A 75 0 SHEET 2 4A 3 GLY A 78 GLY A 82 -1 N MET A 80 O ILE A 73 SHEET 3 4A 3 GLU A 105 THR A 106 -1 N THR A 106 O THR A 81 SHEET 1 5A 4 SER A 238 SER A 241 0 SHEET 2 5A 4 GLY A 243 ILE A 247 -1 N VAL A 246 O SER A 238 SHEET 3 5A 4 SER A 281 GLY A 285 -1 N SER A 284 O MET A 245 SHEET 4 5A 4 TYR A 274 ASP A 278 -1 N LEU A 276 O THR A 283 SHEET 1 6A 7 GLU A 65 GLU A 65 0 SHEET 2 6A 7 ILE A 83 ASP A 87 -1 N TYR A 86 O GLU A 65 SHEET 3 6A 7 GLN A 99 SER A 104 -1 N PHE A 101 O GLY A 85 SHEET 4 6A 7 ASN A 37 VAL A 40 1 N VAL A 40 O GLY A 102 SHEET 5 6A 7 ASP A 118 LEU A 123 -1 N ILE A 120 O TRP A 39 SHEET 6 6A 7 THR A 28 ASP A 32 1 N ILE A 30 O GLY A 119 SHEET 7 6A 7 GLY A 16 GLY A 16 -1 N GLY A 16 O VAL A 29 SHEET 1 7A 5 TRP A 190 ASP A 195 0 SHEET 2 7A 5 GLY A 209 ASP A 215 -1 N ALA A 212 O ILE A 192 SHEET 3 7A 5 TRP A 299 LEU A 301 1 N LEU A 301 O ILE A 213 SHEET 4 7A 5 LEU A 221 GLY A 223 -1 N THR A 222 O ILE A 300 SHEET 5 7A 5 GLY A 285 MET A 289 1 N GLU A 287 O LEU A 221 SHEET 1 1AB 6 GLY B 2 LEU B 6 0 SHEET 2 1AB 6 SER B 163 GLY B 168 -1 N VAL B 165 O GLU B 4 SHEET 3 1AB 6 ASP B 149 TYR B 154 -1 N SER B 152 O LEU B 166 SHEET 4 1AB 6 GLN B 308 ALA B 316 -1 N THR B 311 O VAL B 153 SHEET 5 1AB 6 ASN B 318 VAL B 325 -1 N ALA B 323 O TYR B 310 SHEET 6 1AB 6 THR B 176 THR B 176 -1 N THR B 176 O PRO B 324 SHEET 1 1BB 6 GLY B 2 LEU B 6 0 SHEET 2 1BB 6 SER B 163 GLY B 168 -1 N VAL B 165 O GLU B 4 SHEET 3 1BB 6 ASP B 149 TYR B 154 -1 N SER B 152 O LEU B 166 SHEET 4 1BB 6 GLN B 308 ALA B 316 -1 N THR B 311 O VAL B 153 SHEET 5 1BB 6 ASN B 318 VAL B 325 -1 N ALA B 323 O TYR B 310 SHEET 6 1BB 6 LEU B 179 VAL B 184 -1 N VAL B 184 O ASN B 318 SHEET 1 2B 4 PRO B 23 PHE B 27 0 SHEET 2 2B 4 ILE B 18 GLY B 21 -1 N ILE B 20 O GLN B 25 SHEET 3 2B 4 THR B 88 VAL B 91 -1 N GLN B 90 O GLY B 19 SHEET 4 2B 4 ILE B 94 ASP B 96 -1 N ILE B 94 O VAL B 91 SHEET 1 3B 4 GLU B 202 ALA B 205 0 SHEET 2 3B 4 SER B 196 MET B 199 -1 N ILE B 197 O ALA B 205 SHEET 3 3B 4 ILE B 258 ILE B 262 -1 N VAL B 259 O THR B 198 SHEET 4 3B 4 VAL B 265 LEU B 269 -1 N TYR B 267 O PHE B 260 SHEET 1 4B 3 LEU B 71 TYR B 75 0 SHEET 2 4B 3 GLY B 78 GLY B 82 -1 N MET B 80 O ILE B 73 SHEET 3 4B 3 GLU B 105 THR B 106 -1 N THR B 106 O THR B 81 SHEET 1 5B 4 SER B 238 SER B 241 0 SHEET 2 5B 4 GLY B 243 ILE B 247 -1 N VAL B 246 O SER B 238 SHEET 3 5B 4 SER B 281 GLY B 285 -1 N SER B 284 O MET B 245 SHEET 4 5B 4 TYR B 274 ASP B 278 -1 N LEU B 276 O THR B 283 SHEET 1 6B 7 GLU B 65 GLU B 65 0 SHEET 2 6B 7 ILE B 83 ASP B 87 -1 N TYR B 86 O GLU B 65 SHEET 3 6B 7 GLN B 99 SER B 104 -1 N PHE B 101 O GLY B 85 SHEET 4 6B 7 ASN B 37 VAL B 40 1 N VAL B 40 O GLY B 102 SHEET 5 6B 7 ASP B 118 LEU B 123 -1 N ILE B 120 O TRP B 39 SHEET 6 6B 7 THR B 28 ASP B 32 1 N ILE B 30 O GLY B 119 SHEET 7 6B 7 GLY B 16 GLY B 16 -1 N GLY B 16 O VAL B 29 SHEET 1 7B 5 TRP B 190 ASP B 195 0 SHEET 2 7B 5 GLY B 209 ASP B 215 -1 N ALA B 212 O ILE B 192 SHEET 3 7B 5 TRP B 299 LEU B 301 1 N LEU B 301 O ILE B 213 SHEET 4 7B 5 LEU B 221 GLY B 223 -1 N THR B 222 O ILE B 300 SHEET 5 7B 5 GLY B 285 MET B 289 1 N GLU B 287 O LEU B 221 SSBOND 1 CYS A 45 CYS A 50 1555 1555 2.01 SSBOND 2 CYS A 206 CYS A 210 1555 1555 2.01 SSBOND 3 CYS A 249 CYS A 282 1555 1555 2.05 SSBOND 4 CYS B 45 CYS B 50 1555 1555 2.02 SSBOND 5 CYS B 206 CYS B 210 1555 1555 2.01 SSBOND 6 CYS B 249 CYS B 282 1555 1555 2.03 CISPEP 1 THR A 22 PRO A 23 0 -12.10 CISPEP 2 THR B 22 PRO B 23 0 -6.76 SITE 1 AC1 14 ASP A 32 GLY A 34 TYR A 75 GLY A 76 SITE 2 AC1 14 THR A 77 ILE A 120 ILE A 213 ASP A 215 SITE 3 AC1 14 GLY A 217 THR A 218 SER A 219 MET A 289 SITE 4 AC1 14 ILE A 300 HOH A 347 SITE 1 AC2 16 ILE B 30 ASP B 32 GLY B 34 TYR B 75 SITE 2 AC2 16 GLY B 76 THR B 77 PHE B 111 PHE B 117 SITE 3 AC2 16 TYR B 189 ILE B 213 ASP B 215 GLY B 217 SITE 4 AC2 16 THR B 218 SER B 219 MET B 289 HOH B 339 CRYST1 54.100 74.400 76.500 90.00 90.00 100.80 P 1 1 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018484 0.003526 0.000000 0.00000 SCALE2 0.000000 0.013683 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013072 0.00000 MTRIX1 1 -0.786000 0.036000 0.617000 54.29800 1 MTRIX2 1 0.043000 -0.993000 0.113000 43.48100 1 MTRIX3 1 0.616000 0.116000 0.779000 -21.64600 1